1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Macias, M.J. Gervais, V. Civera, C. Oschkinat, H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Nat.Struct.Biol. NSBIEW 2024 1072-8368 7 375 10.1038/75144 10802733 Structural Analysis of Ww Domains and Design of a Ww Prototype 2000 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4364.709 FORMIN BINDING PROTEIN DOMAIN 1 man polymer no no GATAVSEWTEYKTADGKTYYYNNRTLESTWEKPQELK GATAVSEWTEYKTADGKTYYYNNRTLESTWEKPQELK A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HOUSE MOUSE sample 10090 MUS MUSCULUS 562 ESCHERICHIA COLI repository Initial release Version format compliance Version format compliance 1 0 2000-04-20 1 1 2011-05-08 1 2 2011-07-13 PROTOTYPE WW DOMAIN YJQ8WW DOMAIN FROM SACCHAROMYCES CEREVISAE NMR RESTRAINTS FOR THE ENTRY 1E0L PDBE Y PDBE 2000-03-30 REL THE STRUCTURE WAS DETERMINED USING HOMONUCLEAR NMR SPECTROSCOPY LOWEST ENERGY 20 10 NOESY TOCSY 6.5 pH 285 K simulated annealing 1 1. NILGES, M. refinement ARIA/CNS structure solution ARIA CNS CNS 600 Bruker DRX GLY 1 n 1 GLY 1 A ALA 2 n 2 ALA 2 A THR 3 n 3 THR 3 A ALA 4 n 4 ALA 4 A VAL 5 n 5 VAL 5 A SER 6 n 6 SER 6 A GLU 7 n 7 GLU 7 A TRP 8 n 8 TRP 8 A THR 9 n 9 THR 9 A GLU 10 n 10 GLU 10 A TYR 11 n 11 TYR 11 A LYS 12 n 12 LYS 12 A THR 13 n 13 THR 13 A ALA 14 n 14 ALA 14 A ASP 15 n 15 ASP 15 A GLY 16 n 16 GLY 16 A LYS 17 n 17 LYS 17 A THR 18 n 18 THR 18 A TYR 19 n 19 TYR 19 A TYR 20 n 20 TYR 20 A TYR 21 n 21 TYR 21 A ASN 22 n 22 ASN 22 A ASN 23 n 23 ASN 23 A ARG 24 n 24 ARG 24 A THR 25 n 25 THR 25 A LEU 26 n 26 LEU 26 A GLU 27 n 27 GLU 27 A SER 28 n 28 SER 28 A THR 29 n 29 THR 29 A TRP 30 n 30 TRP 30 A GLU 31 n 31 GLU 31 A LYS 32 n 32 LYS 32 A PRO 33 n 33 PRO 33 A GLN 34 n 34 GLN 34 A GLU 35 n 35 GLU 35 A LEU 36 n 36 LEU 36 A LYS 37 n 37 LYS 37 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N TYR 11 A N TYR 11 A O TYR 19 A O TYR 19 A N ASN 22 A N ASN 22 A O GLU 27 A O GLU 27 8 A A H O ASN GLU 22 27 1.58 1 A ARG 24 0.233 SIDE CHAIN 2 A ARG 24 0.230 SIDE CHAIN 3 A ARG 24 0.232 SIDE CHAIN 4 A ARG 24 0.123 SIDE CHAIN 5 A ARG 24 0.122 SIDE CHAIN 6 A ARG 24 0.307 SIDE CHAIN 7 A ARG 24 0.244 SIDE CHAIN 8 A ARG 24 0.305 SIDE CHAIN 9 A ARG 24 0.304 SIDE CHAIN 10 A ARG 24 0.244 SIDE CHAIN 1 A ALA 2 -171.97 120.95 1 A VAL 5 44.62 85.72 1 A SER 6 170.62 -172.06 1 A GLN 34 31.10 36.11 1 A GLU 35 -153.85 24.15 2 A ALA 2 52.14 97.57 2 A THR 3 -114.10 58.10 2 A VAL 5 64.23 128.79 2 A SER 6 81.97 -160.15 2 A GLN 34 -68.71 59.29 2 A GLU 35 -178.32 30.94 2 A LEU 36 -151.74 58.63 3 A THR 3 -119.66 68.98 3 A ALA 4 -108.04 49.53 3 A VAL 5 42.89 81.64 3 A SER 6 171.32 -166.71 3 A ARG 24 -38.63 -30.78 3 A GLN 34 -67.13 57.91 3 A GLU 35 -176.27 31.08 3 A LEU 36 -154.24 51.60 4 A ALA 2 68.67 114.47 4 A ALA 4 -111.21 50.28 4 A VAL 5 59.43 136.98 4 A SER 6 78.83 -162.21 4 A ARG 24 -39.77 -31.12 4 A GLN 34 -68.48 59.97 4 A GLU 35 -177.40 31.29 4 A LEU 36 -148.56 41.62 5 A ALA 2 -177.93 132.59 5 A ALA 4 -110.83 50.78 5 A VAL 5 46.50 81.72 5 A SER 6 166.72 -170.77 5 A GLN 34 -68.54 59.62 5 A GLU 35 -177.82 31.69 5 A LEU 36 -152.76 48.63 6 A ALA 2 -179.82 -76.07 6 A THR 3 -158.93 72.06 6 A ALA 4 -106.45 50.07 6 A VAL 5 55.44 77.94 6 A SER 6 167.71 -162.47 6 A GLU 35 -176.37 32.66 6 A LEU 36 -151.05 45.52 7 A ALA 2 -166.05 94.30 7 A ALA 4 -98.18 50.60 7 A VAL 5 61.02 129.22 7 A SER 6 66.76 -91.37 7 A GLU 7 36.00 30.57 7 A GLN 34 30.54 35.35 7 A GLU 35 -156.80 24.62 8 A ALA 2 -153.85 46.11 8 A THR 3 -97.75 45.36 8 A ALA 4 -96.69 50.95 8 A VAL 5 65.01 81.85 8 A SER 6 175.55 -167.14 8 A GLN 34 -68.81 59.33 8 A GLU 35 -177.25 32.07 8 A LEU 36 -153.35 60.78 9 A ALA 2 62.14 121.09 9 A THR 3 -150.62 76.53 9 A ALA 4 -98.43 48.49 9 A VAL 5 65.36 86.95 9 A SER 6 171.34 -159.85 9 A PRO 33 -84.62 49.93 9 A GLN 34 30.91 37.28 9 A GLU 35 -154.69 25.05 10 A THR 3 -161.11 73.37 10 A ALA 4 -107.45 49.21 10 A VAL 5 63.31 81.94 10 A SER 6 167.61 -166.62 10 A GLN 34 31.27 35.96 10 A GLU 35 -154.17 23.86 FORMIN BINDING PROTEIN FBP28WW domain from Mus musculus 1 N N SH3 DOMAIN SH3 DOMAIN, WW DOMAIN, FBP28, SIGNAL TRANSDUCTION Q61051 UNP 1 Q61051 1 26 1E0L 1 37 Q61051 A 1 1 37 3 anti-parallel anti-parallel A TRP 8 A TRP 8 A THR 13 A THR 13 A LYS 17 A LYS 17 A ASN 23 A ASN 23 A LEU 26 A LEU 26 A TRP 30 A TRP 30 1 P 1